Menu Search

Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase12 Jan 2026Cosmos Health IncCOSM:NAQGrigorios SiokasChief Executive Officer and Chairman of the Board; Chief Executive Officer and Operations Manager of SkyPharm SA113,1850.5036
USD		57.00k USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer3602.61
USD		940.00 USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer182.61
USD		47.00 USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer1802.61
USD		470.00 USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer1802.61
USD		470.00 USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer2962.61
USD		773.00 USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer182.61
USD		47.00 USD
Purchase12 Jan 2026RENN Global Entrepreneurs Fund IncRENN:ASQMurray StahlChairman of the Board, President, Co-Portfolio Manager and Chief Executive Officer822.61
USD		214.00 USD
Sale12 Jan 2026Zymeworks IncZYME:NSQKenneth GalbraithChairman of the Board, Chief Executive Officer and President30,42422.67
USD		689.82k USD
Sale12 Jan 2026UiPath IncPATH:NYQDaniel DinesChairman of the Board and Chief Executive Officer45,00016.61
USD		747.43k USD
Purchase12 Jan 2026Triplepoint Venture Growth BDC CorpTPVG:NYQJames P. LabeChairman of the Board and Chief Executive Officer23,7996.66
USD		158.51k USD
Purchase12 Jan 2026Triplepoint Venture Growth BDC CorpTPVG:NYQSajal K. SrivastavaDirector, Secretary, Treasurer, President and Chief Investment Officer23,7996.66
USD		158.51k USD
Sale12 Jan 2026Werewolf Therapeutics IncHOWL:NSQLuke B. EvninChairman of the Board58,9800.57
USD		33.62k USD
Purchase12 Jan 2026Kingfisher PLCKGF:LSELucinda RichesNon-Executive Director15,0003.23
GBP		48.39k GBP
Purchase12 Jan 2026Centrica PLCCNA:LSEChristopher Michael O'SheaExecutive Director,Chief Executive Officer831.81
GBP		150.00 GBP
27582 total results

Director dealings news

More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
www.morningstar.com